Diagnosis and management of drug-associated interstitial lung disease

British Journal of Cancer
N L MüllerA Gemma

Abstract

Symptoms of drug-associated interstitial lung disease (ILD) are nonspecific and can be difficult to distinguish from a number of illnesses that commonly occur in patients with non-small-cell lung cancer (NSCLC) on therapy. Identification of drug involvement and differentiation from other illnesses is problematic, although radiological manifestations and clinical tests enable many of the alternative causes of symptoms in advanced NSCLC to be excluded. In lung cancer patients, high-resolution computed tomography (HRCT) is more sensitive than a chest radiograph in evaluating the severity and progression of parenchymal lung disease. Indeed, the use of HRCT imaging has led to the recognition of many distinct patterns of lung involvement and, along with clinical signs and symptoms, helps to predict both outcome and response to treatment. This manuscript outlines the radiology of drug-associated ILD and its differential diagnosis in NSCLC. An algorithm that uses clinical tests to exclude alternative diagnoses is also described.

References

May 1, 1990·AJR. American Journal of Roentgenology·N L MüllerR R Miller
Jul 1, 1983·Canadian Anaesthetists' Society Journal·D S Klein, P R Wilds
Jan 15, 1980·Cancer·A U BuzdarG R Blumenschein
Jun 1, 1995·American Journal of Clinical Oncology·M P RiveraD A White
Feb 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H L Goldberg, S B Vannice
Jan 15, 1996·Annals of Internal Medicine·R K Ramanathan, C P Belani
Feb 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MeradT Le Chevalier
Jun 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A BookmanR F Ozols
Oct 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K A SembP Oian
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S GroegerK Price
Oct 6, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M L DunsfordK Tung
Sep 19, 2000·Radiographics : a Review Publication of the Radiological Society of North America, Inc·S E RossiP C Goodman
Sep 23, 2000·AJR. American Journal of Roentgenology·S J EllisN L Müller
Nov 30, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A L ThomasK J O'Byrne
Jun 29, 2001·Current Opinion in Oncology·S H AbidM C Perry
Sep 12, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·G FogartyD Rischin
Feb 2, 2002·American Journal of Clinical Oncology·Niraj GuptaBhoomi Mehrotra
May 4, 2002·Seminars in Roentgenology·Jeremy J ErasmusSantiago E Rossi
May 17, 2002·Clinical Radiology·Joanne R CleverleyNestor L Müller
Aug 26, 1961·JAMA : the Journal of the American Medical Association·J S LIEBERMANI S WRIGHT
Jan 30, 2004·Fundamental & Clinical Pharmacology·Fabrice BarlésiJean-Pierre Kleisbauer
Aug 10, 2005·Seminars in Respiratory and Critical Care Medicine·Jeffrey L MyersStephen J Swensen

❮ Previous
Next ❯

Citations

Apr 25, 2013·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyeong-Hyun KimHui-Young Lee
Sep 1, 2011·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Tetsuya HommaMitsuru Adachi
Oct 24, 2008·The New England Journal of Medicine·Charles M WienerEugene J Mark
Dec 19, 2012·Acta Oncologica·Eivind StoraasHans Petter Eikesdal
Apr 1, 2006·Current Medical Research and Opinion·Keunchil Park, Koichi Goto
Jan 21, 2006·AJR. American Journal of Roentgenology·Carolina A SouzaMasanori Akira
Jul 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira OnoNobuyuki Yamamoto
Nov 21, 2018·Radiology·Mizuki NishinoF Stephen Hodi
Oct 27, 2009·International Journal of Clinical Oncology·Katsuki MuneokaKatsuyoshi Hatakeyama
Sep 2, 2004·British Journal of Cancer·T HigenbottamY Fujita
Jul 4, 2012·International Journal of Clinical Oncology·Yuka Horiuchi-YamamotoShoji Kudoh
Nov 16, 2012·International Journal of Clinical Oncology·Yoshinobu Saito, Akihiko Gemma
Jan 2, 2014·Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes·Stanisław SadłoBartosz Piechowicz
May 19, 2020·American Society of Clinical Oncology Educational Book·Carey K AndersAlexandra Thomas
Aug 19, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R Shah
Feb 8, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Nariaki KokuhoAkira Shimizu
Sep 13, 2017·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Mizuki NishinoNikhil H Ramaiya
May 26, 2017·JCO Precision Oncology·Mizuki NishinoNikhil H Ramaiya
Mar 16, 2016·Wiener klinische Wochenschrift·Ozge GumusayAhmet Ozet
Jan 3, 2021·Journal of Cancer Research and Clinical Oncology·Taichi MatsubaraTatsuro Okamoto
Jan 21, 2021·International Journal of Molecular Sciences·Tohru OhmoriHironori Sagara
May 8, 2021·Journal of Medicinal Chemistry·Zhenxing WuTingjun Hou
Apr 21, 2006·Seminars in Ultrasound, CT, and MR·C Isabela S Silva, Nestor L Müller
Dec 1, 2009·Seminars in Roentgenology·Jeffrey T Chapman
Oct 15, 2021·JAMA Oncology·Paolo TarantinoGiuseppe Curigliano

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
lavage
biopsies
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.